NGM · Medical - Devices

TLSI (TLSI) Stock

$4.35 +0.69% NGM: TLSI Healthcare

Valuation

MetricValue
Price$4.35
Market Cap$164.91M
P/E Ratio-3.33
P/B Ratio18.87
P/S Ratio3.96
EPS (TTM)$-0.25
52-Week High$7.95
52-Week Low$2.20
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE162.57%
ROA-38.48%
ROCE-47.35%
Gross Margin-60.00%
Operating Margin-60.00%
Net Margin-60.85%
Debt/Equity2.69
Current Ratio2.91

Annual Financials (USD)

Metric20212022202320242025
Revenue$8.0M$12.0M$19.0M$29.0M$45.0M
Operating Profit$-24.0M$-36.0M$-54.0M$-36.0M$-27.0M
Net Profit$-29.0M$-47.0M$-59.0M$-33.0M$-39.0M
EPS$-0.92$-1.59$-2.23$-1.25$-1.84
Op Margin-286.1%-293.9%-294.3%-122.9%-59.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$38.0M$22.0M$25.0M$24.0M$35.0M
Total Liabilities$7.0M$34.0M$52.0M$50.0M$69.0M
Cash$30.0M$9.0M$12.0M$9.0M$20.0M
Borrowings$0$2.0M$2.0M$24.0M$34.0M

Latest News

TriSalus Life Sciences to Host Second Quarter 2026 Financial Results Conference Call Business Wire · Jul 16, 2026 QuidelOrtho (QDEL) Moves 32.2% Higher: Will This Strength Last? Zacks · Jun 30, 2026 TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Liver Cancer Business Wire · Jun 10, 2026 Top Midday Decliners MT Newswires · May 13, 2026 TriSalus Life Sciences Inc (TLSI) Q1 2026 Earnings Call Highlights: Strategic Expansion and ... GuruFocus.com · May 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-23.0M$-32.0M$-51.0M$-41.0M$-18.0M
Investing Cash Flow$-4.0M$-3.0M$-2.0M$-1.0M$-2.0M
Financing Cash Flow$0$0$46.0M$-3.0M$0
Net Cash Flow$26.0M$-21.0M$2.0M$-3.0M$12.0M
Free Cash Flow$-24.0M$-33.0M$-51.0M$-41.0M$-19.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.05
EV / EBITDA-7.43
FCF Yield-11.42%
Quick Ratio5.46
Interest Coverage-4.86
Return 1Y-18.88%
Return 3Y-61.89%
Return 5Y-58.05%

Ownership

Insiders Held34.05%
Institutions Held34.59%
Institutions Float Held52.44%
Institutional HolderSharesReport Date
First Light Asset Management, LLC5,066,8272026-03-31
AWM Investment Company, Inc.2,079,1052026-03-31
Nantahala Capital Management, LLC2,070,8272026-03-31
Blackrock Inc.1,499,5472026-03-31
Vanguard Capital Management LLC1,347,0362026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARMPArmata Pharmaceuticals, Inc. $4.64 -0.43% -0.60 $170.34M 0.00%
AVR $8.28 +0.00% -2.56 $304.61M 0.00%
CATX $3.00 +1.01% -2.59 $342.14M 0.00%
LNSR $5.25 -1.87% 6.53 $63.55M 0.00%
MXCT $1.18 +6.31% -2.55 $126.40M 0.00%

About TLSI

TLSI is led by CEO Mary T. Szela, employs 110 people, headquartered in US, publicly traded since 2021.

TLSI stock trades at $4.35 with a market capitalization of $164.91M. The stock is valued at a price-to-earnings (P/E) ratio of -3.33, price-to-book of 18.87, price-to-sales of 3.96. Over the past 52 weeks the stock has ranged between $2.20 and $7.95, and currently trades 45.3% below its 52-week high.

On profitability, TLSI generates a return on equity (ROE) of 162.57% — well above the market average, a sign of a high-quality business, return on capital employed of -47.35%, an operating margin of -60.00%, a net profit margin of -60.85%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides